Lakshmi Chivukula
About Lakshmi Chivukula
Lakshmi Chivukula is a Fellow in Translational Biochemistry & Pharmacology, focusing on the interaction of pathogenic yeast with nanostructured surfaces and its implications for drug resistance.
Lakshmi Chivukula - Fellow in Translational Biochemistry & Pharmacology
Lakshmi Chivukula holds the title of Fellow in Translational Biochemistry & Pharmacology. Her work focuses on advancing the understanding and application of biochemical processes and pharmacological principles. She specializes in the translational aspect, which involves converting scientific discoveries into practical medical solutions. Her expertise lies in the interface between biochemistry and pharmacology, concentrating on the development and validation of therapeutic assays.
Lakshmi Chivukula's Education and Expertise
Lakshmi Chivukula earned her Ph.D. in Nanoscience from the University of North Carolina Greensboro. Her educational background provides a solid foundation for her research in biochemistry and pharmacology. With a particular focus on nanostructured surfaces, her work examines the interactions between pathogenic yeast and these surfaces. Her expertise extends to understanding how these interactions influence sterol quantity and antifungal drug resistance in pathogenic yeast.
Research on Pathogenic Yeast and Nanostructured Surfaces by Lakshmi Chivukula
Lakshmi Chivukula has conducted significant research into the mechanisms of interaction between pathogenic yeast and nanostructured surfaces. Her investigations explore how these interactions impact the sterol content and antifungal drug resistance of yeast. This research is crucial for developing more effective antifungal treatments and understanding the resistance mechanisms in pathogenic yeast.
Lakshmi Chivukula's Work with 1910 Genetics' AI Platforms
Lakshmi Chivukula is involved in developing and validating biochemical and cell-based high throughput screening assays for 1910 Genetics. Utilising the company's AI-powered platforms, ELVIS™ and ROSALYND™, she works on therapeutics designed to address various medical conditions. Her role is pivotal in ensuring that these assays are effective and reliable, contributing to the advancement of AI-driven therapeutic development.